Multiomics Market Size Set to Reach USD 8,696.36 Million by 2032, Growing at a CAGR of 15.3%

The market growth is propelled by progressions in technology, such as cloud-dependent and single-cell technology.

NEW YORK CITY, NY, UNITED STATES, September 11, 2024 /EINPresswire.com/ -- 𝐓𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐦𝐮𝐥𝐭𝐢𝐨𝐦𝐢𝐜𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐬𝐢𝐳𝐞 𝐢𝐬 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐠𝐫𝐨𝐰 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 15.3% 𝐟𝐫𝐨𝐦 2024 𝐭𝐨 2032, 𝐚𝐜𝐜𝐨𝐫𝐝𝐢𝐧𝐠 𝐭𝐨 𝐚 𝐧𝐞𝐰 𝐫𝐞𝐩𝐨𝐫𝐭 𝐩𝐮𝐛𝐥𝐢𝐬𝐡𝐞𝐝 𝐛𝐲 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡. 𝐓𝐡𝐞 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐫𝐞𝐯𝐞𝐚𝐥𝐬 𝐭𝐡𝐚𝐭 𝐭𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐰𝐚𝐬 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 𝐔𝐒𝐃 2,782.37 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 2024 𝐚𝐧𝐝 𝐢𝐬 𝐞𝐱𝐩𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 𝐔𝐒𝐃 8,696.36 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2032.

𝐌𝐮𝐥𝐭𝐢𝐨𝐦𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐯𝐢𝐞𝐰:
Multiomics is a comprehensive perspective of biology that attaches awareness from genomics, proteomics, transcriptomics, and alternate omics. They provide scientists with a more absolute comprehension of cellular and organismal reason. It offers researchers a method to analyze procedures that are excessively intricate with any person ome to seize on their own and render contemporary progressions in biology, medicine, and other areas.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.polarismarketresearch.com/industry-analysis/multiomics-market/request-for-sample

𝐅𝐚𝐜𝐭𝐨𝐫𝐬 𝐁𝐨𝐨𝐬𝐭𝐢𝐧𝐠 𝐌𝐮𝐥𝐭𝐢𝐨𝐦𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐄𝐯𝐨𝐥𝐮𝐭𝐢𝐨𝐧:
• Progression in Customized Medicines: Multiomics warrants comprehensive perspectives into the biological occurrence, pushing progression in customized medicines and accurate agriculture. The market growth is pushed by growing funding in R&D. For instance, in June 2021, SCIEX embarked on OneOmics suite software and the Molecule Profiler app.

• Growing Cases of Detrimental Illnesses: The escalating detrimental illnesses such as diabetes, cancer, heart disease, and others ease the requirement for multiomics software and solutions to comprehend intricate molecular data. The growing prevalence of detrimental illnesses pushes the multiomics market during the forecast period.

• Technological Progressions: Technological progressions play an active part in pushing the growth of the market. Single-cell multi-omics combined with progressive technology such as AI and data analytics sanction profound inspection of distinct cells and offer perspectives into proteomics, metabolomics, genomics, & transcriptomics. These progressions amidst contenders have configured tactical associations and partnerships to serve the demand for single-cell multi-omics-based software.

• Growing Investments in R&D: Growing investments in research and development play an important part in the market. Several government firms and market contenders are funded to enhance the progression of human well-being and illness. Industry learning partnership concentrates on contemporary technology advancement for multi-omics applications, charting the significance of customized medicines in premature disease detection, which are assisting in multiomics market CAGR.

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:

𝐓𝐡𝐞 𝐫𝐞𝐩𝐨𝐫𝐭 𝐝𝐢𝐯𝐢𝐝𝐞𝐬 𝐭𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐦𝐮𝐥𝐭𝐢𝐨𝐦𝐢𝐜𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐨𝐧 𝐭𝐡𝐞 𝐛𝐚𝐬𝐢𝐬 𝐨𝐟 𝐩𝐫𝐨𝐝𝐮𝐜𝐭 & 𝐬𝐞𝐫𝐯𝐢𝐜𝐞, 𝐭𝐲𝐩𝐞, 𝐩𝐥𝐚𝐭𝐟𝐨𝐫𝐦, 𝐚𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧, 𝐚𝐧𝐝 𝐫𝐞𝐠𝐢𝐨𝐧.

• Product & services: the market is segregated into products, instruments, consumables, software artillery shells, and services. The products segment held the largest multiomics market share due to the growing acquisition of single-cell multi-omics with the incorporation of progressive technology additionally pushes the segment growth in the market.

• By type, the market is segmented into single-cell multi-omics and bulk-cell multi-omics. The single-cell multi-omics segment dominated the market, driven by its usage in several applications such as developmental biology, cancer biology, gene therapy, stem cell biology, and operational screening.

• By platform, the market is divided into Genomics, Transcriptomics, Proteomics, Metabolomics, and Integrated Omics Platforms.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐚 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐨𝐧 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐁𝐞𝐟𝐨𝐫𝐞 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞:
https://www.polarismarketresearch.com/industry-analysis/multiomics-market/request-for-discount-pricing

𝐀𝐠𝐠𝐫𝐞𝐬𝐬𝐢𝐯𝐞 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞
The escalating funding in R&D for drug detection and contemporary technology are affirmatively influencing the market. The continuing augmentation inventiveness involving alliances, accession, and partnerships is igniting contention in the marketplace.

𝐓𝐡𝐞 𝐦𝐮𝐥𝐭𝐢𝐨𝐦𝐢𝐜𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐤𝐞𝐲 𝐩𝐥𝐚𝐲𝐞𝐫𝐬 𝐩𝐫𝐨𝐟𝐢𝐥𝐞𝐝 𝐢𝐧 𝐭𝐡𝐞 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞:
• BD
• Thermo Fisher Scientific, Inc.
• Illumina, Inc.
• Danaher (Beckman Coulter)
• PerkinElmer, Inc.
• Shimadzu Corporation
• Bruker
• QIAGEN

𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐒𝐮𝐩𝐫𝐞𝐦𝐚𝐜𝐲:
Based on region, North America dominated the multiomics market because of the growing detrimental illnesses in the region. For instance, according to figures produced by the Canadian Cancer Society in 2023, approximately 239,100 people were detected with cancer in Canada, with deaths around 20%.

𝐈𝐧𝐪𝐮𝐢𝐫𝐞 𝐦𝐨𝐫𝐞 𝐚𝐛𝐨𝐮𝐭 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐛𝐞𝐟𝐨𝐫𝐞 𝐩𝐮𝐫𝐜𝐡𝐚𝐬𝐞:
https://www.polarismarketresearch.com/industry-analysis/multiomics-market/inquire-before-buying

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐥 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰:

By Products & Services Outlook:
• Products
• Instruments
• Consumables
• Software Artillery Shells
• Services

By Type Outlook:
• Single-cell Multi-omics
• Bulk Multi-omics

By Platform Outlook:
• Genomics
• Transcriptomics
• Proteomics
• Metabolomics
• Integrated Omics Platforms

By Application Outlook:
• Cell Biology
• Oncology
• Neurology
• Immunology

By Region Outlook:
• North America (US, Canada)
• Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
• Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
• Latin America (Brazil, Mexico, Argentina)
• Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

𝐁𝐫𝐨𝐰𝐬𝐞 𝐏𝐌𝐑'𝐬 𝐌𝐮𝐥𝐭𝐢𝐨𝐦𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐂𝐨𝐯𝐞𝐫𝐚𝐠𝐞 𝐟𝐫𝐨𝐦 𝐃𝐢𝐟𝐟𝐞𝐫𝐞𝐧𝐭 𝐏𝐮𝐛𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬:

𝐓𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐦𝐮𝐥𝐭𝐢-𝐨𝐦𝐢𝐜𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐬𝐢𝐳𝐞 𝐢𝐬 𝐞𝐱𝐩𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 𝐔𝐒𝐃 8,696.36 𝐌𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2032, 𝐞𝐱𝐡𝐢𝐛𝐢𝐭𝐢𝐧𝐠 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 15.3% 𝐝𝐮𝐫𝐢𝐧𝐠 𝐭𝐡𝐞 𝐟𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐩𝐞𝐫𝐢𝐨𝐝.

𝐅𝐀𝐐𝐬:
How much is the Multiomics Market?
The global multiomics market size was valued at USD 2,426.21 million in 2023 and is projected to grow to USD 8,696.36 million by 2032.

What is the growth rate of the market?
The global market is projected to exhibit a CAGR of 15.3% during the forecast period, 2024-2032.

Which region held the largest market share in the multiomics market?
North America had the largest share of the global market.

Who are the key players in the market?
The key players in the market are BD (US), Thermo Fisher Scientific, Inc. (US), Illumina, Inc. (US), Danaher (Beckman Coulter) (US), PerkinElmer, Inc. (US), Shimadzu Corporation (Japan), Bruker (US), QIAGEN (Germany), Agilent Technologies, Inc. (US), and BGI Genomics (China).

Which type held the highest share in the market?
The Single-cell multi-omics segment category held the highest share of the market in 2023.

𝐁𝐫𝐨𝐰𝐬𝐞 𝐌𝐨𝐫𝐞 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭𝐬:

𝐏𝐲𝐫𝐨𝐠𝐞𝐧 𝐓𝐞𝐬𝐭𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭:
https://www.polarismarketresearch.com/industry-analysis/pyrogen-testing-market

𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐓𝐫𝐢𝐚𝐥 𝐏𝐚𝐭𝐢𝐞𝐧𝐭 𝐑𝐞𝐜𝐫𝐮𝐢𝐭𝐦𝐞𝐧𝐭 𝐒𝐞𝐫𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭:
https://www.polarismarketresearch.com/industry-analysis/clinical-trial-patient-recruitment-services-market

𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐒𝐢𝐦𝐮𝐥𝐚𝐭𝐢𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭:
https://www.polarismarketresearch.com/industry-analysis/healthcare-simulation-market

𝐌𝐢𝐜𝐫𝐨𝐛𝐢𝐨𝐦𝐞 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭:
https://www.polarismarketresearch.com/industry-analysis/microbiome-diagnostics-market

𝐂𝐲𝐬𝐭𝐚𝐭𝐢𝐧 𝐂 𝐀𝐬𝐬𝐚𝐲 𝐌𝐚𝐫𝐤𝐞𝐭:
https://www.polarismarketresearch.com/industry-analysis/cystatin-c-assay-market

𝐀𝐛𝐨𝐮𝐭 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 & 𝐂𝐨𝐧𝐬𝐮𝐥𝐭𝐢𝐧𝐠, 𝐈𝐧𝐜:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR’s clientele spread across different enterprises. We at Polaris are obliged to serve PMR’s diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR’s customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR’s customers.

Likhil G
Polaris Market Research and Consulting
+1 929-297-9727
sales@polarismarketresearch.com
Visit us on social media:
Facebook
X
LinkedIn